Trials testing psychedelics for treating substance abuse disorders
Clinical Research News highlights addiction speaker series presentation
Clinical Research News highlighted a presentation from the University of Cincinnati's Davide Amato and Jon Kostas, executive director of the Association for Prescription Psychedelics, discussing current trials testing psychedelics to treat substance use disorders. Amato and Kostas spoke at the Center for Addiction Research's Summer Speaker Series Aug. 13.
Amato gave an overview of the history of psychedelics and research on their use to treat substance use disorder. He noted former names for the class of drugs such as "psychotomimetics" and "hallucinogens" can be misleading.
“In the context of psychosis, altered perception is very different,” said Amato, PhD, associate professor in UC's James L. Winkle College of Pharmacy. He said psychosis is diagnosed based on persistent symptoms including delusions and a loss of adherence to reality, while psychedelic experiences can be marked by increased ratings in positive attitudes, mood and social effects.
Amato and his colleagues are publishing research soon that summarizes current studies registered at ClinicalTrials.gov and identifies rebalancing of the brain’s dopamine system as the means by which psychedelics might help blunt drug-seeking behavior and promote drug abstinence. The article has been accepted for publication by the British Journal of Pharmacology.
Read the Clinical Research News article.
Featured photo at top of mushrooms. Photo/Christopher Ott/Unsplash.
Related Stories
Why so much hype around the new Grand Theft Auto?
November 6, 2026
UC experts from DAAP's game and animation program to a doctor at the Lindner Center of HOPE discuss the pros and cons surrounding the upcoming billion-dollar game Grand Theft Auto VI.
Are you experiencing “post-election stress disorder”?
November 6, 2026
Feelings of stress and anxiety tied to election results can persist even after the votes are counted, said University of Cincinnati psychiatrist Julia Stimpfl, MD, even though “post-election stress disorder” is not officially recognized as a mental illness. As she recently told Spectrum News 1 Ohio, those feelings can linger even after an election is finalized.
New UC research identifies biological differences in pancreatic cancer
November 6, 2026
University of Cincinnati Cancer Center research published in Cancer Research found differences in pancreatic cancer tumors and immune environments, opening the possibility for more personalized treatments.